[{"data":1,"prerenderedAt":154},["ShallowReactive",2],{"drug-naphazoline-pheniramine":3},{"id":4,"schemaVersion":5,"name":6,"category":9,"class":10,"brands":13,"synonyms":19,"formulations":25,"regimens":38,"contraindications":55,"warnings":74,"renal":82,"monitoring":83,"interactions":84,"review":85,"examples":88,"atc":94,"iran":96,"usApproval":124,"links":130,"populations":144},"naphazoline-pheniramine",1,{"fa":7,"en":8},"قطره چشمی نافازولین + فنیرامین","Naphazoline + pheniramine eye drops","sensory-organs",{"fa":11,"en":12},"ضداحتقان + آنتی‌هیستامین چشمی","Ocular decongestant + antihistamine",[14,17],{"name":15,"market":16},"Naphcon-A","US",{"name":18,"market":16},"Visine-A",[20,21,22,23,24],"naphcon-a","visine","نفکن","قطره قرمزی چشم","نافازولین",[26],{"id":27,"form":28,"route":29,"label":30,"concentration":31,"markets":33,"refs":34},"drops","eye-drops","ophthalmic","Naphazoline 0.02675% + pheniramine 0.315%",{"amount":5,"unit":32,"perUnit":32},"drop",[16],[35],{"source":36,"section":37},"fda-naphcon","Active Ingredients",[39],{"id":40,"disease":41,"label":42,"population":45,"type":49,"unit":32,"dose":50,"refs":52},"ac","allergic-conjunctivitis",{"fa":43,"en":44},"خارش و قرمزی آلرژیک چشم — ۶ سال به بالا: ۱ تا ۲ قطره تا ۴ بار در روز","Allergic itch and redness — ≥6 y: 1–2 drops up to 4 times daily",{"minAge":46},{"value":47,"unit":48},6,"year","fixed",{"perDose":5,"dosesPerDay":51},4,[53],{"source":36,"section":54},"Directions",[56,65],{"id":57,"severity":58,"text":59,"refs":62},"glaucoma","warn",{"fa":60,"en":61},"گلوکوم زاویه بسته، بیماری قلبی، فشار خون، بزرگی پروستات: پیش از مصرف با پزشک.","Narrow-angle glaucoma, heart disease, high blood pressure, enlarged prostate: ask a doctor first.",[63],{"source":36,"section":64},"Warnings — Ask a doctor before use",{"id":66,"severity":58,"text":67,"refs":70,"rule":72},"lt6",{"fa":68,"en":69},"زیر ۶ سال با پزشک.","Under 6 years: ask a doctor.",[71],{"source":36,"section":54},{"maxAge":73},{"value":47,"unit":48},[75],{"text":76,"refs":79},{"fa":77,"en":78},"مصرف زیاد قرمزی را بیشتر می‌کند؛ ممکن است مردمک موقتاً گشاد شود.","Overuse may cause more redness; pupils may dilate temporarily.",[80],{"source":36,"section":81},"Warnings — When using this product",[],[],[],{"status":86,"reviewer":87,"date":87},"unverified",null,[89],{"regimen":40,"formulation":27,"input":90,"expect":93},{"ageYears":91,"weightKg":92},20,60,{"perDose":5},[95],"S01GA51",{"status":97,"forms":98,"refs":119},"registered",[99,103,107,111,115],{"code":100,"en":101,"fa":102},"00886","NAPHAZOLINE 0.05% 10ML NASAL DROP","قطره بینی نافازولین ۰٫۰۵ درصد ۱۰ میلی‌لیتر",{"code":104,"en":105,"fa":106},"11861","NAPHAZOLINE 0.05% NASAL SPRAY","اسپری بینی نافازولین ۰٫۰۵ درصد",{"code":108,"en":109,"fa":110},"00887","NAPHAZOLINE 0.1% 10ML OPH DROP","قطره چشمی نافازولین ۰٫۱ درصد ۱۰ میلی‌لیتر",{"code":112,"en":113,"fa":114},"51887","NAPHAZOLINE HYDROCHLORIDE SPRAY NASAL 0.05 % 15 mL","اسپری بینی نافازولین هیدروکلراید ۰٫۰۵ درصد ۱۵ میلی‌لیتر",{"code":116,"en":117,"fa":118},"52233","NAPHAZOLINE HYDROCHLORIDE SOLUTION, DROPS OPHTHALMIC 0.1 % 0.5 mL","قطره چشمی نافازولین هیدروکلراید ۰٫۱ درصد ۰٫۵ میلی‌لیتر",[120],{"source":121,"section":122,"url":123},"darooyab-generic","G-2201\u002FNaphazoline","https:\u002F\u002Fwww.darooyab.ir\u002FG-2201\u002FNaphazoline",{"kind":125,"refs":126,"id":129},"NDA",[127],{"source":36,"section":128},"SPL approval \u002F marketing category","NDA020065",[131,134,138,141],{"kind":132,"url":133,"label":129},"fda","https:\u002F\u002Fwww.accessdata.fda.gov\u002Fscripts\u002Fcder\u002Fdaf\u002Findex.cfm?event=overview.process&ApplNo=020065",{"kind":135,"url":136,"label":137},"dailymed","https:\u002F\u002Fdailymed.nlm.nih.gov\u002Fdailymed\u002FdrugInfo.cfm?setid=253130b4-a23b-43a0-b125-0fa5bd01b2b6","FDA Naphazoline+phenir.",{"kind":139,"url":140,"label":95},"who-atc","https:\u002F\u002Fatcddd.fhi.no\u002Fatc_ddd_index\u002F?code=S01GA51",{"kind":142,"url":123,"label":143},"darooyab","Naphazoline",{"pregnancy":145},{"level":146,"quote":147,"text":148,"refs":151},"caution","مصرف در بارداری نفازولین گروه C در شرايط خاص و نظارت ويژه پزشك قابل استفاده است:",{"fa":149,"en":150},"دارویاب: گروه C — فقط اگر فایده بیشتر از خطر باشد.","Darooyab: category C — only if benefit outweighs risk.",[152],{"source":121,"section":153,"url":123},"G-2201\u002FNaphazoline — مصرف در بارداری",1792100114814]